Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Leclercq

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
American Journal of Ophthalmology|February 16, 2022
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 PatientsGeorgina Maalouf, Anaïs Andrillon, Mathilde Leclercq, et al.
Ophthalmology|May 21, 2025
Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysisMathilde Leclercq, Robin Jacquot, Camille Charbonnier, et al.
Joint Bone Spine|September 21, 2023
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysisRomain Foré, Eric Liozon, Stéphanie Dumonteil, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
The Lancet. Neurology|November 24, 2025
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO<sub>2</sub>MSE): a prospective, multicentre case-control studyPhilippe Ryvlin, Margaux Huot, Luc Valton, et al.
American Journal of Ophthalmology|February 5, 2026
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trialDavid Saadoun, Amine Ghembaza, Sarah Touhami, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
American Journal of Ophthalmology|February 16, 2022
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 PatientsGeorgina Maalouf, Anaïs Andrillon, Mathilde Leclercq, et al.
Ophthalmology|May 21, 2025
Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysisMathilde Leclercq, Robin Jacquot, Camille Charbonnier, et al.
Joint Bone Spine|September 21, 2023
BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysisRomain Foré, Eric Liozon, Stéphanie Dumonteil, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
The Lancet. Neurology|November 24, 2025
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO<sub>2</sub>MSE): a prospective, multicentre case-control studyPhilippe Ryvlin, Margaux Huot, Luc Valton, et al.
American Journal of Ophthalmology|February 5, 2026
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trialDavid Saadoun, Amine Ghembaza, Sarah Touhami, et al.
Pageof 4